Mutations in the p53 tumour suppressor gene in thyroid tumours of children from areas contaminated by the Chernobyl accident

International Journal of Radiation Biology

Volumn 69, Issue 1, 1996, Pages 39-45

  Hillebrandt, S ^a   Streffer, C ^a   Reiners, Chr ^a   Demidchik, E ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Thyroid Cancer Center   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHERNOBYL ACCIDENT; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SCHOOL CHILD; THYROID CANCER; TUMOR SUPPRESSOR GENE;

ACCIDENTS, RADIATION; ADOLESCENT; ADULT; CARCINOMA, PAPILLARY; CHILD; DNA, NEOPLASM; ELECTROPHORESIS; EXONS; FEMALE; GENE AMPLIFICATION; GENES, P53; HUMANS; MALE; NEOPLASMS, RADIATION-INDUCED; POINT MUTATION; POLYMERASE CHAIN REACTION; POWER PLANTS; THYROID NEOPLASMS; UKRAINE;

EID: 0029933129     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530096146165     Document Type: Article

References (25)

1. BARNES, D. M., DUBLIN, E. A., FISHER, C. J., LEVISON, D. A. and MILLIS, R. R., 1993, Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? Human Pathology, 24, 469-476.
2. BAVERSTOCK, K., EGLOFF, P., PINCHERA, A., RUCHTI, C. and WILLIAMS, D., 1992, Thyroid cancer after Chernobyl. Nature, 359, 21-22.
3. DOCKHORN-DWORNICZAK, B., SCHRÖDER, S., DANTCHEVA, R., TÖTSCH, M., STÜCKER, A., BRÖMMELKAMP, E., BANKFALVI, A., BÖCKER, W. and SCHMID, K. W., 1993, The role of the p53 tumor suppressor gene in human thyroid cancer. Experimental Clinical Endocrinology, 101, 39-46.
4. FAGIN, J. A., MATSUO, K., KARMAKAR, A., CHEN, D. L., TANG, S. H. and KOEFFLER, H. P., 1993, High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. Journal of Clinical Investigations, 91, 179-184.
5. GREENBLATT, M. S., BENNETT, W. P., HOLLSTEIN, M. and HARRIS, C. C., 1994, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research, 54, 4855-4878.
6. HARRIS, C. C. and HOLLSTEIN, M., 1993, Clinical implications of the p53 tumor-suppressor gene. New England Journal of Medicine, 28, 1318-1327.
7. HEI, T. K., BEDFORD, J. and WALDREN, C. A., 1994, p53 mutation hotspot in radon-associated lung cancer. Lancet, 343, 1158-1159.
8. IGGO, R., GATTER, K., BARTEK, J., LANE, D. and HARRIS, A. L., 1990, Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675-679.
9. ITO, T., SEYAMA, T., MIZUNO, T., TSUYAMA, N., HAYASHI, T., HAYASHI, Y., DOHI, K., NAKAMURA, N. and AKIYAMA, M., 1992, Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Research, 52, 1369-1371.
10. ITO, T., SEYAMA, T., IWAMOTO, K. S., MIZUNO, T., TRONKO, N., KOMISSARENKO, I. V., CHERSTOVOY, E. D., SATOW, Y., TAKELCHI, N., DOHI, K. and AKLYAMA, M., 1994, Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet, 344, 259.
11. MCWHIRTER, W. R. and PETROESCHEVSKY, A. L., 1990, Childhood cancer incidence in Queensland, 1978-88. International Journal of Cancer, 45, 1002-1005.
12. PURDIE, C. A., O'GRADY, J., PIRIS, J., WYLLIE, A. and BIRD, C., 1991, p53 expression in colorectal tumors. American Journal of Pathology, 138, 807-813.
13. RIESNER, D., STEGER, G., ZIMMAT, R., OWENS, R. A., WAGENHÖFER, M., HILLEN, W., VOLLBACH, S. and HENCO, K., 1989, Temperature-gradient gel electrophoresis of nucleic acids: analysis of conformational transitions, sequence variations, and protein-nucleic acid interactions. Electrophoresis, 10, 377-389.
14. SOUSSI, T., DE FROMENTEL, C. and MAY, P., 1990, Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5, 945-952.
15. TAYLOR, J. A., WATSON, M. A., DEVEREUX, T. R., MICHELS, R. Y., SACCOMANNO, G. and ANDERSON, M., 1994, p53 mutation hotspot in radon-associated lung cancer. Lancet, 343, 86-87.
16. THOR, A. D., MOORE, D. H., EDGERTON, S. M., KAWASAKI, E. S., REIHSAUS, E. and LYNCH, H. T., 1992, Accumulation of p53 tumor supressor gene protein: an independent marker of prognosis in breast cancer. Journal of the National Cancer Institute, 84, 845-855.
17. VAN DEN BERG, M., TIGGES, A. J., SCHIPPER, M. E., DEN HARTOJAGER, F. C., KROES, W. G. and WALBOOMERS, J. M., 1989, expression of the nuclear oncogene p53 in colon tumours. Journal of Pathology, 157, 193-199.
18. VÄHÄKANGAS, K. H., SAMET, J. M., METCALF, R. A., WELSH, J. A., BENNETT, W. P., LANE, D. P. and HARRIS, C. C., 1992, Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet, 339, 576-579.
19. VENITT, S. and BIGGS, P. J., 1994, Radon, mycotoxins, p53, and uranium mining. Lancet, 343, 795.
20. WILLIAMS, D., PINCHERA, A., KARAOGLOU, A. and CHADWICK, K. H., 1993, Thyroid cancer in children living near Chernobyl. Commission of the European Communities. Radiation Protection Research and Training Programme, 1-108.
21. WRIGHT, P. A., LEMOINE, N. R., GORETZKI, P. E., WYLLIE, F. S., BOND, J. and HUGHES, C., 1991, Mutation of the p53 in a differentiated human thyroid carcinoma. Oncogene, 6, 1693-1697.
22. WRIGHT, P. A., WILLIAMS, E. D., LEMOINE, N. R. and WYNFORD-THOMAS, D., 1991, Radiation associated and 'spontaneous' human thyroid carcinoma show a different pattern of ras oncogene mutation. Oncogene, 6, 471-473.
23. WU, X., BAYLE, J. H., OLSON, D. and LEVINE, A. J., 1993, The p53-mdm-2 autoregulatory feedback loop. Genes Development, 7, 1126-1132.
24. YOUNG, J. L., RIES, L. G., SILVERBERG, E., HORM, J. W. and MILLER, R. W., 1986, Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer, 58, 598-602.
25. ZOU, M., SHI, Y. and FARAD, N. R., 1993, p53 mutations in all stages of thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism, 77, 1054-1058.